Uptake of Gadolinium-Based Contrast Agents by Blood Cells During Contrast-Enhanced MRI Examination

GDD/ToxicityCellular/Mitochondria dysfunctionFibrosis
Written By Bridget Belo

Article Link: https://journals.lww.com/investigativeradiology/fulltext/2024/05000/uptake_of_gadolinium_based_contrast_agents_by.3.aspx

Journal: Investigative Radiology

Authors and Affiliations: Ruprecht, Nico PhD; Parakkattel, Dixy MSci; Hofmann, Lukas PhD; Broekmann, Peter PhD; Lüdi, Nicola DIPL; Kempf, Christoph PhD; Heverhagen, Johannes Thomas MD, PhD; von Tengg-Kobligk, Hendrik MD

From the Department of Diagnostic, Interventional, and Pediatric Radiology, Bern University Hospital, University of Bern, Bern, Switzerland (N.R., D.P., C.K., J.T.H., H.v.T.-K.); Experimental Radiology Laboratory, Department of BioMedical Research, University of Bern, Bern, Switzerland (N.R., D.P., C.K., J.T.H., H.v.T.-K.); Department of Chemistry, Faculty of Exact Sciences and Institute of Nanotechnology and Advanced Materials, Bar Ilan University, Israel (L.H.); and Department of Chemistry, Biochemistry and Pharmaceutical Sciences (DCBP), University of Bern, Bern, Switzerland (P.B., N.L.).

Bridget Belo
Previous

Gadolinium Effects on Liposome Fluidity and Size Depend on the Headgroup and Side Chain Structure of Key Mammalian Brain Lipids (Dec 2023).
Next

Gadolinium Deposition Disease Current State of Knowledge and Expert Opinion (2023).